Erschienen in:
20.01.2021 | Short Communication
The prognostic impact of peritoneal washing cytology for otherwise resectable extrahepatic cholangiocarcinoma patients
verfasst von:
Tatsuaki Sumiyoshi, Kenichiro Uemura, Naru Kondo, Kenjiro Okada, Shingo Seo, Hiroyuki Otsuka, Masahiro Serikawa, Yasutaka Ishii, Norimasa Kuraoka, Takuya Sakoda, Kenta Baba, Takumi Harada, Yoshiaki Murakami, Shinya Takahashi
Erschienen in:
Surgery Today
|
Ausgabe 7/2021
Einloggen, um Zugang zu erhalten
Abstract
The clinical importance of peritoneal washing cytology (PWC) for cholangiocarcinoma patients remains unclear. The clinical data of 137 extrahepatic cholangiocarcinoma patients who received PWC and curative surgery were retrospectively analyzed. Among the 137 patients analyzed, five (3.6%) had positive PWC, and 132 (96.4%) had negative PWC. The median survival time in patients with negative PWC was 6.45 years, and the overall 1-, 2-, and 5-year survival rates were 86.5%, 75.3%, and 51.6%, respectively. The median survival time in patients with positive PWC was 2.56 years, and the overall 1-, 2-, and 5-year survival rates were 60.0%, 60.0%, and 40.0%, respectively. A multivariate analysis revealed that positive lymph node metastasis (P < 0.001), positive perineural invasion (P = 0.014) and no use of adjuvant chemotherapy (P < 0.001), but not positive PWC were independently associated with a worse overall survival. In conclusion, surgery and subsequent chemotherapy might be a therapeutic option for cholangiocarcinoma patients with positive PWC.